Man’s 9 items CTCs Early Screening
Mechanism of angiogenesis is induced when the tumor continuing to divide and proliferate. Tumor cells will fall off from the new blood vessels into the blood circulation and forming as circulating tumor cells (CTCs).
Per gram of malignant tumor has about 1 million tumor cells can be released into the blood. mRNA dynamic gene technology can detect the number of CTCs; therefore, it could screen out and detect the ultra-early stage of Tumor (0.2 cm or above) by investigating CTCs. mRNA dynamic gene technology is up to 93-97% of accuracy, sensitivity and specificity by non-invasive and safe technology.
Listed Price is $18,000 and now is $4,800 for the promotional period! Please contact 3168-8188, WhatsApp 6218-8534 or Facebook inbox for more information.
Click Here:To know more about mRNA Circulating Tumor Cells Screening
Man’s 9 items CTCs Early ScreeningmRNA-9Cancer-M | ||
Characteristics: | ||
Very early detection of Circulating Tumor Cells (CTCs) | ||
Detecting tumor is 0.2cm or larger | ||
Screening 9 types of common Tumor | ||
Covering 56 mRNA molecular marker | ||
Accuracy, sensitivity and specificity are up to 93-97% | ||
Non-invasive and inflicting minimal harm | ||
Suitable for: | ||
Family history of cancer | ||
Overweight and lack of exercise | ||
Unhealthy eating, smoking and eating habits | ||
Frequent exposure under radiation and polluted environments | ||
Highly health conscious people | ||
9 CTCs screening: | ||
Lung | ||
Liver | ||
Stomach | ||
Pancreatic | ||
Colorectal | ||
Head and Neck | ||
Nasopharyngeal Carcinoma | ||
Breast | ||
Prostate | ||
New Advanced technology- mRNA Circulating Tumor Cells Screening | ||
Technology R & D: Eegene International Biotechnology Company Limited |
HKD$8,000 HKD$4,800 |